Glycoscience & Therapy
Glycoscience & Therapy
Following nucleic acid and protein, glycan is the third chain of life, playing key roles in physiological and pathological system. However, glycan has huge amount of structure motifs. Theoretically, u...
Following nucleic acid and protein, glycan is the third chain of life, playing key roles in physiological and pathological system. However, glycan has huge amount of structure motifs. Theoretically, understanding their structure and function will help to understand the physiological and pathological principle in human life and provide multiple potential strategies for therapy against diseases. Hence, Glycoscience & Therapy is a major journal covers the study and exploitation of glycans structure, sequencing, function, synthesis, metabolism, evolution, glycomics in physiological and pathological process and the glycan-based new drug discovery associated natural glycans preparation, structure characterization, glycan and derivative synthesis, bioactivity, structure and activity relationship, target discovery, pharmacodynamic evaluation, action mechanism, polysaccharide absorption, pharmacokinetics, pharmaceutical preparation, etc.
Glycobiology and Molecular Biology: Molecular glycobiology, Glycoscience databases
Biomedical Applications: Glycoimmunology, Glycopathology, Glycoscience and disease, Cancer glycobiology, Glycoscience and neurobiology, Glycoscience in drug development, Immunotherapy, Glycobiomarkers, Glycotherapy, Regenerative medicine
Structural Glycobiology: Glycoprotein structure, Glycolipid structure, NMR spectroscopy in glycoscience, X-ray crystallography in glycobiology, Computational glycobiology, Molecular dynamics simulations, Glycosylation site mapping, Structural glycomics, Glycan-protein interactions, Glycoengineering, glycan sequencing, glycan synthesis, Glycan conformation
Systems Biology and Omics: Systems glycobiology, Glycoproteomics, Glycolipidomics, Glycomic profiling, Glycoscience and genomics, Functional glycomics, Glycoscience and proteomics, Metabolomics in glycoscience, High-throughput glycan analysis, Glycoinformatics
Interdisciplinary Collaborations: Nanotechnology in glycoscience, Environmental glycoscience, Glycoscience and biotechnology, Glycoscience and materials science, Glycoscience and pharmacology, Glycoscience and microbiology, Glycoscience and plant sciences, Glycoscience and chemistry, Bioinformatics in glycoscience, Glycoscience education, Molecular Biology, Biochemistry, Agriculture, Food science.
Society affiliation
http://english.simm.cas.cn/ Founded in1932, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS), has the longest history as a comprehensive research institution for drug discovery in China. In line with the mission of “Discovering new drugs to relieve patients suffering from various diseases”, SIMM has developed and comme...
Founded in1932, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS), has the longest history as a comprehensive research institution for drug discovery in China. In line with the mission of “Discovering new drugs to relieve patients suffering from various diseases”, SIMM has developed and commercialized over 100 new drugs. Since the implementation of the Knowledge Innovation Program of CAS, developing novel drugs has become a paramount research focus of SIMM in recent years. Through several generations’ efforts, SIMM has become one of the leading interdisciplinary centers of excellence in China. It is recognized worldwide by its outstanding achievements and distinguished research team.
https://www.zidd.ac.cn/index.aspx
Zhongshan Institute for Drug Discovery (ZIDD), established in September 2018, is a novel research and development (R & D) institution in China. Adhering to the guiding principles of “clear-cut planning, disciplinary differentiation, platform extension, and division of responsibilities”, ZIDD focuses on innovative drug research and development, technological breakthroughs, biopharmaceutical industry incubation, and talent cultivation, with the aim of establishing an internationally advanced comprehensive drug research institution. Since its inception, ZIDD has centered on original innovation and gathered global biopharmaceutical resources, making continuous progress in providing comprehensive lifecycle solutions for the research and development of First-in-class and Best-in-class drugs, and gradually evolving into a high-level, international research hub.